指南与共识细菌感染、耐药与抗菌药物医院感染防控

假体周围关节感染抑制性抗菌治疗的实践差异、结局与定义:系统综述与专家共识

Practice variation, outcomes and definitions of suppressive antimicrobial therapy for prosthetic joint infections: a systematic review and expert consensus statement.
指南 / 共识 · Clin Infect Dis · 2026-04-13

SAT合并报告成功率在急性PJI经DAIR后为74%(95%CI:63-85%),在慢性PJI经DAIR或无手术者为70%(95%CI:63-78%)。SAT定义报告不一致,通过改良Delphi流程达成共识,区分了SAT与延长抗菌治疗(EAT)。

要点

  • SAT在美国多用于急性PJI经DAIR后,欧洲多用于无治愈意图的PJI。
  • SAT合并成功率:急性PJI经DAIR后74%,慢性PJI经DAIR或无手术70%。
  • 共识推荐使用SAT与EAT的明确定义以统一研究和临床交流。

核心结论

  • PJI文献中SAT定义不一致,美欧实践存在差异,推荐使用共识定义的SAT和EAT以统一研究 and 临床交流。

研究设计与样本

  • 使用非随机研究方法学指数(MINORS)工具评估研究质量,采用随机效应模型合并成功率,通过改良Delphi流程制定定义。

主要发现

  • 美国文献中SAT主要用于急性PJI经DAIR处理后的患者,欧洲研究主要涉及无治愈意图的PJI。
  • SAT合并报告成功率:急性PJI经DAIR后为74%(95%CI:63-85%),慢性PJI经DAIR或无手术者为70%(95%CI:63-78%)。
  • SAT定义报告不一致,共识达成区分SAT与延长抗菌治疗(EAT)的定义。

关键数值与推荐

  • SAT合并成功率:急性PJI经DAIR后74%(95%CI:63-85%)。
  • SAT合并成功率:慢性PJI经DAIR或无手术者70%(95%CI:63-78%)。
  • 共识定义区分SAT与EAT,推荐用于研究和临床沟通。

临床怎么用

  • 临床中应使用共识定义的SAT和EAT,以统一沟通和研究。
  • 注意美欧实践差异:美国SAT多用于急性PJI经DAIR后,欧洲多用于无治愈意图的PJI。

局限性

  • SAT定义报告不一致可能影响结果解读。
  • 研究地域限于美国和欧洲,可能限制普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Literature on periprosthetic joint infection (PJI) contains varying strategies and definitions of suppressive antimicrobial therapy (SAT). This study aimed to describe current SAT strategies, evaluate their clinical outcomes, and establish a consensus definition of SAT for research and clinical purposes. METHODS: Following PRISMA guidelines, a systematic review was performed by searching PubMed and EMBASE from their inception to March 10, 2025. All trials and observational studies including ≥10 patients with PJI treated with SAT were eligible. Data on study, patient, and treatment characteristics, definitions and outcomes were extracted. Study quality was appraised using the Methodological Index for Non-randomized Studies tool. A random effects model was used to pool success rates. Definitions were developed through a modified Delphi process. RESULTS: Forty-two studies (n = 2524 patients) were included: 25 from the United States (U.S.) and 17 from Europe. In U.S. literature, SAT was predominantly prescribed for acute PJI managed with debridement, antibiotics, and implant retention (DAIR), whereas European studies primarily involved PJI managed without curative intent. The pooled reported success rate of SAT was 74% (95% CI: 63-85%) for acute PJI treated with DAIR and 70% (95% CI: 63-78%) for chronic PJI treated with DAIR or without surgery. Definitions of SAT were inconsistently reported. Consensus was achieved, resulting in definitions distinguishing SAT from extended antimicrobial therapy (EAT). CONCLUSION: SAT is inconsistently defined in PJI literature with variation of practice between the U.S. and Europe. To harmonize research and clinical communication, we advocate the use of consensus definitions of SAT and EAT.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hanssen JLJ, Pijls B, Wouthuyzen-Bakker M, et al. Practice variation, outcomes and definitions of suppressive antimicrobial therapy for prosthetic joint infections: a systematic review and expert consensus statement. Clin Infect Dis. 2026. PMID: 41973995. doi:10.1093/cid/ciag251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。